← Back to Search

Hormone Therapy

DHEA + Exercise for Osteoporosis

N/A
Waitlist Available
Led By Julio Carballido-Gamio, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 36 weeks
Awards & highlights

Study Summary

This trial will look at the effects of a common steroid hormone, DHEA, and exercise on bone marrow fat and bone strength in older women.

Who is the study for?
Postmenopausal women aged 55-85 with low bone mass or moderate osteoporosis, not currently doing high impact exercise more than twice a week, willing to do a 36-week exercise program and take DHEA or placebo. Must have completed COVID vaccination, no severe health issues like uncontrolled diabetes, recent cancer treatment (except skin cancer), heart disease, or metal implants if participating in MRI study.Check my eligibility
What is being tested?
The trial is testing the effects of the hormone DHEA and an exercise program on bone marrow fat among older women with bone loss. The goal is to understand how these interventions could improve bone strength by affecting the microenvironment within bones over a period of 36 weeks.See study design
What are the potential side effects?
Potential side effects from taking DHEA may include oily skin, acne, hair loss, stomach upset, high blood pressure changes in menstrual cycle for those who are not fully menopausal. Exercise might cause muscle soreness or injury if not done properly.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~36 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 36 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in hip bone marrow fat content
Changes in spine bone marrow fat content
Correlation of hip bone marrow fat content with hip strength at baseline
+3 more
Other outcome measures
spatial distribution of the changes in bone marrow fat content of the hip
spatial distribution of the changes in bone marrow fat content of the spine

Trial Design

4Treatment groups
Experimental Treatment
Group I: no exercise and placeboExperimental Treatment2 Interventions
no supervised bone-loading exercise and one placebo pill per day for 36 weeks
Group II: no exercise and DHEAExperimental Treatment2 Interventions
no supervised bone exercise and one dose of DHEA (50 milligrams) per day for 36 weeks
Group III: Exercise and placeboExperimental Treatment2 Interventions
supervised bone-loading exercise 3 days per week and one placebo pill per day for 36 weeks
Group IV: Exercise and DHEAExperimental Treatment2 Interventions
supervised bone-loading exercise 3 days per week and one dose of DHEA (50 milligrams) per day for 36 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise
2016
Completed Phase 1
~760
DHEA
2004
Completed Phase 4
~2080

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,732 Previous Clinical Trials
2,143,531 Total Patients Enrolled
11 Trials studying Osteoporosis
1,180 Patients Enrolled for Osteoporosis
Julio Carballido-Gamio, PhDPrincipal InvestigatorUniversity of Colorado, Denver
Catherine Jankowski, PhDPrincipal InvestigatorUniversity of Colorado, Denver
3 Previous Clinical Trials
262 Total Patients Enrolled
2 Trials studying Osteoporosis
259 Patients Enrolled for Osteoporosis

Media Library

DHEA (Hormone Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05316272 — N/A
DHEA (Hormone Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05316272 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who makes a viable participant for this clinical experiment?

"To qualify, applicants must have diminished bone density and be aged between 55 to 85 years. This research project is looking for approximately 52 participants in total."

Answered by AI

Does this clinical trial allow for participants aged 50 years or older?

"Applicants aged 55 to 85 are eligible for this medical trial. Meanwhile, there are 18 trials available for those under the age of majority and 137 options available for seniors above 65 years old."

Answered by AI

Are there any available positions for participants in this experiment?

"This research endeavour is no longer recruiting participants, as evidenced by the clinicaltrials.gov information which was last updated on March 30th 2022. Although this trial has concluded its recruitment period, there are 159 other studies actively looking for volunteers at present."

Answered by AI

Who else is applying?

What state do they live in?
Ohio
Illinois
Other
Georgia
How old are they?
18 - 65
What site did they apply to?
University of Colorado Anschutz Medical Campus
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
2
0

Why did patients apply to this trial?

add to body of knowledge about osteoporosis. Making changes to have a healthier and better me.
PatientReceived 2+ prior treatments
I am very interested in excercising to prevent and improve osteoporosis. I've tried other methods for Osteoporosis treatment and really want to pursue a trial without the side effects of current medications. I've also worked hard on diet, and more natural approaches. Thank you.
PatientReceived 1 prior treatment

What questions have other patients asked about this trial?

I would like to know how many times I would need to come to Colorado?
PatientReceived 1 prior treatment
~17 spots leftby Apr 2025